{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:54:55Z","timestamp":1790013295984,"version":"4.0.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions in the elderly. Despite advances in burr-hole craniotomy, up to one-third of patients experience clinically significant recurrences, and most are not suitable candidates for repeat surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To summarize current surgical concepts and clinical evidence for middle meningeal artery embolization (MMAE) in CSDH and integrate this data with our current understanding of the molecular and cellular mechanisms that drive disease persistence and response to treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We detail the epidemiology and standard surgical management of CSDH, discuss prospective and randomized evidence for the use of MMAE as adjunctive, primary, or salvage therapy, and synthesize experimental and clinical data on inflammation, angiogenesis, and coagulation in the CSDH neomembrane. We then summarize mechanistic hypotheses regarding how MMAE alters this microenvironment and highlight future directions, including biomarker development and AI-assisted precision therapy. Unlike previous reviews that focused primarily on clinical outcomes, this article highlights the biological mechanisms underlying MMAE efficacy and their impact on precise patient selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Recent randomized controlled trials of MMAE have yielded mixed but encouraging results. Some trials have shown a reduction in relapse or treatment failure with adjunctive MMAE, whereas others have failed to achieve primary endpoints. Heterogeneity in study design, patient selection, and outcome definitions limits direct comparison. Mechanistic studies demonstrate that CSDH is a vascularized and inflamed microenvironment nourished by fragile MMA-derived vessels. Embolization may reduce microbleeding, dampen inflammation, and promote hematoma resorption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>By targeting underlying vascular and inflammatory processes, MMAE is a promising adjunct and, in selected cases, an alternative strategy for CSDH. However, current evidence is heterogeneous, and further studies are needed to define its safety, efficacy, and cost-effectiveness. Integration of mechanistic information with biomarker and imaging-based approaches may improve patient selection and treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1756744","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:33:49Z","timestamp":1782970429000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Middle meningeal artery embolization in chronic subdural hematoma: bridging surgical innovations and molecular mechanisms"],"prefix":"10.3389","volume":"13","author":[{"given":"Rasit","family":"Dinc","sequence":"first","affiliation":[{"name":"INVAMED Medical Innovation Institute","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurittin","family":"Ardic","sequence":"additional","affiliation":[{"name":"Med-International UK Health Agency Ltd.","place":["Nuneaton, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3171\/2018.12.JNS183035","article-title":"The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population","volume":"132","author":"Rauhala","year":"2019","journal-title":"J Neurosurg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-017-0881-y","article-title":"Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy","volume":"14","author":"Edlmann","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3171\/2016.8.JNS16134","article-title":"The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom","volume":"127","author":"Brennan","year":"2017","journal-title":"J Neurosurg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1148\/radiol.2017170053","article-title":"Middle meningeal artery embolization for chronic subdural hematoma","volume":"286","author":"Ban","year":"2018","journal-title":"Radiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1056\/NEJMoa2313472","article-title":"Adjunctive middle meningeal artery embolization for subdural hematoma","volume":"391","author":"Davies","year":"2024","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1056\/NEJMoa2409845","article-title":"Embolization of the middle meningeal artery for chronic subdural hematoma","volume":"392","author":"Fiorella","year":"2025","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa2401201","article-title":"Middle meningeal artery embolization for nonacute subdural hematoma","volume":"391","author":"Liu","year":"2024","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jama.2025.7583","article-title":"Meningeal embolization for preventing chronic subdural hematoma recurrence after surgery: the EMPROTECT randomized clinical trial","volume":"334","author":"Shotar","year":"2025","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.18.00138","article-title":"Natural language processing for automated quantification of brain metastases reported in free-text radiology reports","volume":"3","author":"Senders","year":"2019","journal-title":"JCO Clin Cancer Inform"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00234-020-02558-x","article-title":"Radiological prognostic factors of chronic subdural hematoma recurrence: a systematic review and meta-analysis","volume":"63","author":"Miah","year":"2021","journal-title":"Neuroradiology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(09)61115-6","article-title":"Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial","volume":"374","author":"Santarius","year":"2009","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3171\/2017.6.JNS17130","article-title":"Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation","volume":"129","author":"Motiei-Langroudi","year":"2018","journal-title":"J Neurosurg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/bc.bc_65_23","article-title":"Featured minimally invasive therapeutic approach for chronic subdural hematoma: embolization of middle meningeal artery\u2014a narrative review","volume":"10","author":"Dinc","year":"2024","journal-title":"Brain Circ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/neuros\/nyaa379","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations","volume":"88","author":"Kan","year":"2021","journal-title":"Neurosurgery"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1623619","DOI":"10.3389\/fsurg.2025.1623619","article-title":"Adjunctive role of middle meningeal artery embolization in patients with surgical treatment of unilateral chronic subdural hematoma: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Wach","year":"2025","journal-title":"Front Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1016\/j.wneu.2022.12.042","article-title":"Cost comparison for open surgery versus middle meningeal artery embolization in patients with chronic subdural hematomas: a propensity score-matched analysis","volume":"172","author":"Salih","year":"2023","journal-title":"World Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"109128","DOI":"10.1016\/j.clineuro.2025.109128","article-title":"Middle meningeal artery embolisation reduces chronic subdural haematoma recurrence: a meta-analysis of EMBOLISE, STEM, MAGIC-MT and EMPROTECT trials and cost analysis","volume":"258","author":"Jayakumar","year":"2025","journal-title":"Clin Neurol Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1017\/cjn.2021.503","article-title":"Grading scale for embolization of middle meningeal artery for chronic subdural hematoma","volume":"50","author":"Shankar","year":"2023","journal-title":"Can J Neurol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/neurintsurg-2021-018073","article-title":"Radiographic clearance of chronic subdural hematomas after middle meningeal artery embolization","volume":"14","author":"Catapano","year":"2022","journal-title":"J Neurointerv Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00011-012-0476-0","article-title":"Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study","volume":"61","author":"Stanisic","year":"2012","journal-title":"Inflamm Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e90149","DOI":"10.1371\/journal.pone.0090149","article-title":"The correlation between pro- and anti-inflammatory cytokines in chronic subdural hematoma patients assessed with factor analysis","volume":"9","author":"Pripp","year":"2014","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0660","article-title":"Relationship between neutrophil extracellular traps and venous thromboembolism: pathophysiological and therapeutic role","volume":"86","author":"Dinc","year":"2025","journal-title":"Br J Hosp Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3171\/jns.1976.45.1.0026","article-title":"Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma","volume":"45","author":"Ito","year":"1976","journal-title":"J Neurosurg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.wneu.2017.09.063","article-title":"Chronic subdural hematoma: a perspective on subdural membranes and dementia","volume":"108","author":"Sahyouni","year":"2017","journal-title":"World Neurosurg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ctn9010004","article-title":"Therapeutic role of microglia\/macrophage polarization in intracerebral hemorrhage","volume":"9","author":"Dinc","year":"2025","journal-title":"Clin Transl Neurosci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3171\/jns.2000.93.4.0686","article-title":"Middle meningeal artery embolization for refractory chronic subdural hematoma","volume":"93","author":"Mandai","year":"2000","journal-title":"Case Report. J Neurosurg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1089\/neu.2005.22.518","article-title":"Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma","volume":"22","author":"Hohenstein","year":"2005","journal-title":"J Neurotrauma"},{"key":"B28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.32604\/biocell.2024.050097","article-title":"The pathogenesis of chronic subdural hematoma in the perspective of neomembrane formation and related mechanisms","volume":"48","author":"Huang","year":"2024","journal-title":"Biocell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1089\/neu.2020.7042","article-title":"Expression of angiopoietins and angiogenic signaling pathway molecules in chronic subdural hematomas","volume":"37","author":"Isaji","year":"2020","journal-title":"J Neurotrauma"},{"key":"B30","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/jcm11040902","article-title":"Serum levels of MMP-8 and MMP-9 as markers in chronic subdural hematoma","volume":"11","author":"Su","year":"2022","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/2152-7806.116679","article-title":"Usefulness of embolization of the middle meningeal artery for refractory chronic subdural hematomas","volume":"4","author":"Hashimoto","year":"2013","journal-title":"Surg Neurol Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s007010050093","article-title":"Local hypercoagulative activity precedes hyperfibrinolytic activity in the subdural space during development of chronic subdural haematoma from subdural effusion","volume":"140","author":"Kudo","year":"1998","journal-title":"Acta Neurochir"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00701-005-0616","article-title":"Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence","volume":"147","author":"Stanisic","year":"2005","journal-title":"Acta Neurochir"},{"key":"B34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/2152-7806.73801","article-title":"Efficacy of middle meningeal artery embolization in the treatment of refractory chronic subdural hematoma","volume":"1","author":"Mino","year":"2010","journal-title":"Surg Neurol Int"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.21037\/cdt-20-763","article-title":"Development and validation of a prognostic prediction model for antithrombotic-related chronic subdural hematoma in patients with recent acute myocardial infarction","volume":"10","author":"Zhou","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1007\/s00018-016-2268-0","article-title":"Transition from inflammation to proliferation: a critical step during wound healing","volume":"73","author":"Land\u00e9n","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/1591019918769336","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: endovascular technique and radiographic findings","volume":"24","author":"Link","year":"2018","journal-title":"Interv Neuroradiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/15910199221104631","article-title":"Radiographic and clinical outcomes with particle or liquid embolic agents for middle meningeal artery embolization of nonacute subdural hematomas","volume":"29","author":"Scoville","year":"2023","journal-title":"Interv Neuroradiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1016\/j.wneu.2019.02.121","article-title":"Midterm follow-up of patients with middle meningeal artery embolization in intractable chronic subdural hematoma","volume":"126","author":"Okuma","year":"2019","journal-title":"World Neurosurg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/acn3.50923","article-title":"PAI-1 5G\/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients","volume":"6","author":"Szegedi","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/02688697.2021.1886245","article-title":"Trial of dexamethasone for chronic subdural hematoma","volume":"37","author":"David","year":"2023","journal-title":"Br J Neurosurg"},{"key":"B42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13063-021-05907-0","article-title":"Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial","volume":"23","author":"Immenga","year":"2022","journal-title":"Trials"},{"key":"B43","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3171\/2024.1.JNS232463","article-title":"Efficacy and safety of tranexamic acid in the management of chronic subdural hematoma: a systematic review and meta-analysis","volume":"141","author":"Musmar","year":"2024","journal-title":"J Neurosurg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1209","DOI":"10.1016\/j.wneu.2022.05.143","article-title":"Urokinase is safe and effective in reducing recurrence in chronic subdural hematoma after burr-hole drainage","volume":"164","author":"Cheung","year":"2022","journal-title":"World Neurosurg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1007\/s10753-025-02318-0","article-title":"The evolution and recurrence of chronic subdural hematoma was associated with different distribution of macrophage M1\/M2 polarization","volume":"48","author":"Yi","year":"2025","journal-title":"Inflammation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jamaneurol.2018.2030","article-title":"Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized ClinicalTrial","volume":"75","author":"Jiang","year":"2018","journal-title":"JAMA Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/02688697.2016.1260686","article-title":"Risk factors for recurrence of chronic subdural hematoma after burr hole surgery: potential protective role of dexamethasone","volume":"31","author":"Qian","year":"2017","journal-title":"Br J Neurosurg"},{"key":"B48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/ATVBAHA.114.303927","article-title":"Angiogenic microvascular endothelial cells release microparticles rich in tissue factor that promotes postischemic collateral vessel formation","volume":"35","author":"Arderiu","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.3390\/ijms23147548","article-title":"Promising strategies for preserving adult endothelium health and reversing its dysfunction: from liquid biopsy to new omics technologies and noninvasive circulating biomarkers","volume":"23","author":"Balistreri","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B50","first-page":"3348","article-title":"MicroRNA-21 and microRNA-146a negatively regulate the secondary inflammatory response of microglia after intracerebral hemorrhage","volume":"11","author":"Wang","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/cns.12019","article-title":"Circulating MicroRNAs as potential risk biomarkers for hematoma enlargement after intracerebral hemorrhage","volume":"18","author":"Zheng","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"B52","doi-asserted-by":"publisher","first-page":"12147","DOI":"10.18632\/aging.102550","article-title":"Hematoma-derived exosomes of chronic subdural hematoma promote abnormal angiogenesis and inhibit hematoma absorption through miR-144-5p","volume":"11","author":"Gao","year":"2019","journal-title":"Aging"},{"key":"B53","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00701-020-04218-8","article-title":"Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach","volume":"162","author":"Edlmann","year":"2020","journal-title":"Acta Neurochir"},{"key":"B54","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.wneu.2018.05.037","article-title":"Pathophysiology and nonsurgical treatment of chronic subdural hematoma: from past to present to future","volume":"116","author":"Holl","year":"2018","journal-title":"World Neurosurg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/j.wneu.2020.12.014","article-title":"Segmentation of chronic subdural hematomas using 3D convolutional neural networks","volume":"148","author":"Kellogg","year":"2021","journal-title":"World Neurosurg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e54944","DOI":"10.2196\/54944","article-title":"Combining clinical-radiomics features with machine learning methods for building models to predict postoperative recurrence in patients with chronic subdural hematoma: retrospective cohort study","volume":"26","author":"Fang","year":"2024","journal-title":"J Med Internet Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1585299","DOI":"10.3389\/fcvm.2025.1585299","article-title":"AI-driven decision making for intravascular device selection in aortic disease","volume":"12","author":"Dinc","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamasurg.2019.4917","article-title":"Artificial intelligence and surgical decision-making","volume":"155","author":"Loftus","year":"2020","journal-title":"JAMA Surg"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1756744\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:33:50Z","timestamp":1782970430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1756744\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":58,"alternative-id":["10.3389\/fsurg.2026.1756744"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1756744","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1756744"}}